@julianajfigueroa's weight loss endorsement lacks key details

What did @julianajfigueroa actually say?

Straightforwardly: nothing medically meaningful. The transcript is song lyrics, or something close to it. The words "chart the constellations in his eyes" and "the lowest way is never luck" are not weight-loss advice, GLP-1 commentary, or health claims of any kind. The only context pointing toward weight loss is the caption, the hashtags, and the tagged spa account.

It is worth being honest here: there is no verbal claim to fact-check in this video. The creator did not say anything about semaglutide, tirzepatide, appetite suppression, insulin sensitivity, or body weight. The video falls into a very common TikTok pattern where a transformation or lifestyle clip gets tagged into a health category purely through hashtags like #weightloss and #skinny, while the audio is ambient, musical, or lyrical. That does not make it harmful, but it does make it essentially content-free from a medical standpoint.

Does the science back this up?

There is no scientific claim to evaluate here. The transcript contains zero factual assertions about GLP-1 medications or weight loss physiology. That said, the tagging of this video into the GLP-1 category reflects a real trend worth addressing with actual data.

GLP-1 receptor agonists like semaglutide and tirzepatide have meaningful clinical evidence behind them. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide producing up to 20.9% mean body weight reduction over 72 weeks in adults with obesity. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg producing approximately 14.9% mean weight loss versus 2.4% for placebo. These are real, substantial effects. But they come with real side effects, real contraindications, and real discontinuation rates that rarely show up in hashtag-driven TikTok content.

What did they get wrong (or right)?

The creator did not get anything medically wrong because they did not say anything medical. That is about as exonerating a fact-check as it is a disappointing one.

What the video does contribute to, passively, is the broader ecosystem of aspirational weight-loss content on TikTok that surrounds GLP-1 medications. Research from Triassi et al. (2023, JMIR Infodemiology) found that a significant proportion of weight-loss content on short-form video platforms lacks any clinical context, and that hashtag-driven discoverability pushes viewers toward content regardless of whether it contains actual information. A video that says nothing about GLP-1 medications but sits inside that hashtag cluster still shapes expectations. The #skinny hashtag in particular has documented associations with disordered eating content, per a 2022 review in the International Journal of Eating Disorders. That is not the creator's fault per se, but it is worth naming plainly.

What should you actually know?

If you found this video while researching GLP-1 medications, here is what actually matters. GLP-1 receptor agonists work by mimicking a naturally occurring hormone that slows gastric emptying, reduces appetite signaling in the hypothalamus, and stimulates glucose-dependent insulin secretion. They are not a shortcut, and they are not appropriate for everyone.

The most common side effects include nausea, vomiting, constipation, and diarrhea, particularly during dose escalation. Serious but rarer risks include pancreatitis, gallbladder disease, and, in rodent studies (not confirmed in humans), thyroid C-cell tumors, which is why these medications carry a black box warning for patients with a personal or family history of medullary thyroid carcinoma or MEN2.

• GLP-1 medications require a prescription from a licensed provider.
• Compounded versions of semaglutide and tirzepatide are not equivalent to FDA-approved brand-name drugs. Do not assume they are interchangeable.
• Weight regain after discontinuation is well-documented. Wilding et al. (2022, Diabetes, Obesity and Metabolism) found participants regained two-thirds of lost weight within one year of stopping semaglutide.
• The #skinny framing in weight-loss content often conflates low body weight with health, which is not what the clinical literature supports.